ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 159 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2018. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $311,000 | -31.9% | 7,267 | +1.0% | 0.33% | -36.5% |
| Q2 2019 | $457,000 | -19.0% | 7,193 | -11.6% | 0.51% | -21.3% |
| Q1 2019 | $564,000 | +70.9% | 8,136 | +7.3% | 0.65% | +47.5% |
| Q4 2018 | $330,000 | -22.4% | 7,581 | +36.1% | 0.44% | +5.5% |
| Q3 2018 | $425,000 | +10.4% | 5,570 | +11.2% | 0.42% | +20.7% |
| Q2 2018 | $385,000 | +4.3% | 5,011 | -30.8% | 0.35% | +3.3% |
| Q1 2018 | $369,000 | +20.6% | 7,245 | +26.4% | 0.34% | +46.1% |
| Q4 2017 | $306,000 | – | 5,733 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $4,658,000 | 2.63% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,364,434 | $84,745,000 | 1.21% |
| CAPITAL INTERNATIONAL LTD /CA/ | 259,700 | $16,130,000 | 1.07% |
| Aureus Asset Management, LLC | 65,670 | $4,079,000 | 0.69% |
| Capital International Sarl | 124,320 | $7,722,000 | 0.67% |
| CAPITAL GUARDIAN TRUST CO | 512,430 | $31,827,000 | 0.58% |
| ROCKEFELLER FINANCIAL SERVICES INC | 408,379 | $25,365,000 | 0.50% |
| Rock Springs Capital Management LP | 160,500 | $9,969,000 | 0.50% |
| Hood River Capital Management LLC | 112,296 | $6,975,000 | 0.48% |
| Capital International, Inc./CA/ | 52,700 | $3,273,000 | 0.47% |